• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基磺酸盐抑制剂S4影响结肠癌细胞中碳酸酐酶IX胞外域的脱落。

Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells.

作者信息

Hektoen Helga Helseth, Ree Anne Hansen, Redalen Kathrine Røe, Flatmark Kjersti

机构信息

a Institute of Clinical Medicine, University of Oslo , Oslo , Norway .

b Department of Tumor Biology , Oslo University Hospital , Oslo , Norway .

出版信息

J Enzyme Inhib Med Chem. 2016 Oct;31(5):779-86. doi: 10.3109/14756366.2015.1069286. Epub 2015 Aug 5.

DOI:10.3109/14756366.2015.1069286
PMID:26244271
Abstract

Carbonic anhydrase IX (CAIX) is a pivotal pH regulator under hypoxia, which by its tumor-specific expression represents an attractive target for cancer therapy. Here, we report on effects of the sulfamate CAIX inhibitor S4 (4-(3'-(3″,5″-dimethylphenyl)ureido)phenyl sulfamate) in colorectal carcinoma cell lines. S4 was administered under experimental hypoxia or normoxia to HT29, KM20L2 and HCT116 cells. Effects on survival, proliferation, pH, lactate extrusion and CAIX protein expression were evaluated. S4 treatment resulted in attenuated hypoxia-induced extracellular acidification and reduced clonogenic survival under hypoxia in HT29 cells. The pH effects were present only in a [Formula: see text]-free buffer system and were accompanied by decreased lactate extrusion. The main finding of this work was that S4 treatment caused alterations in CAIX ectodomain shedding. This merits further investigation to understand how sulfamates influence CAIX activity and how such drugs may be of use in cancer treatment.

摘要

碳酸酐酶IX(CAIX)是缺氧条件下关键的pH调节剂,因其在肿瘤中的特异性表达,成为癌症治疗的一个有吸引力的靶点。在此,我们报告氨基磺酸CAIX抑制剂S4(4-(3'-(3″,5″-二甲基苯基)脲基)苯氨基磺酸)对结肠癌细胞系的影响。在实验性缺氧或常氧条件下,将S4作用于HT29、KM20L2和HCT116细胞。评估其对细胞存活、增殖、pH、乳酸外排和CAIX蛋白表达的影响。S4处理导致HT29细胞在缺氧条件下缺氧诱导的细胞外酸化减弱,克隆形成存活率降低。pH效应仅在无[化学式:见原文]缓冲系统中出现,并伴有乳酸外排减少。这项工作的主要发现是S4处理导致CAIX胞外域脱落发生改变。这值得进一步研究,以了解氨基磺酸盐如何影响CAIX活性以及这类药物在癌症治疗中的作用。

相似文献

1
Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells.氨基磺酸盐抑制剂S4影响结肠癌细胞中碳酸酐酶IX胞外域的脱落。
J Enzyme Inhib Med Chem. 2016 Oct;31(5):779-86. doi: 10.3109/14756366.2015.1069286. Epub 2015 Aug 5.
2
The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.氨基磺酸小分子CAIX抑制剂S4调节阿霉素疗效。
PLoS One. 2016 Aug 11;11(8):e0161040. doi: 10.1371/journal.pone.0161040. eCollection 2016.
3
Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor model.氨基磺酸酯碳酸酐酶IX抑制剂S4在喉肿瘤模型中诱导的肿瘤微环境变化
PLoS One. 2014 Sep 16;9(9):e108068. doi: 10.1371/journal.pone.0108068. eCollection 2014.
4
Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.碳酸酐酶 IX 抑制作用影响适应细胞外酸中毒的癌细胞活力。
J Mol Med (Berl). 2017 Dec;95(12):1341-1353. doi: 10.1007/s00109-017-1590-9. Epub 2017 Sep 19.
5
Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.靶向碳酸酐酶 IX 可耗竭乏氧微环境中的乳腺癌干细胞。
Oncogene. 2013 Oct 31;32(44):5210-9. doi: 10.1038/onc.2012.550. Epub 2012 Dec 3.
6
Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.碳酸酐酶 IX 在人乳腺癌细胞中的细胞和放射生物学效应。
Oncol Rep. 2019 Apr;41(4):2585-2594. doi: 10.3892/or.2019.7001. Epub 2019 Feb 5.
7
Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.碳酸酐酶 IX 的抑制通过改变宫颈癌细胞内的 pH 值水平促进细胞凋亡。
Int J Mol Sci. 2021 Jun 5;22(11):6098. doi: 10.3390/ijms22116098.
8
Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers.乌瑞得硫酸盐碳酸酐酶 IX/ XII 抑制剂治疗癌症的临床前评价。
Int J Mol Sci. 2019 Dec 2;20(23):6080. doi: 10.3390/ijms20236080.
9
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.碳酸酐酶 IX 抑制剂 SLC-0111 可增强癌细胞对常规化疗的敏感性。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):117-123. doi: 10.1080/14756366.2018.1532419.
10
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.使用一系列体外乳腺癌模型评估碳酸酐酶IX作为抑制乳腺癌侵袭和转移的治疗靶点。
Oncotarget. 2015 Sep 22;6(28):24856-70. doi: 10.18632/oncotarget.4498.

引用本文的文献

1
Carbonic anhydrase IX inhibitor S4 triggers release of DAMPs related to immunogenic cell death in glioma cells via endoplasmic reticulum stress pathway.碳酸酐酶 IX 抑制剂 S4 通过内质网应激途径触发与免疫原性细胞死亡相关的 DAMPs 在神经胶质瘤细胞中的释放。
Cell Commun Signal. 2023 Jun 29;21(1):167. doi: 10.1186/s12964-023-01180-7.
2
Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies.靶向碳酸酐酶 IX 和 XII 同工型的小分子抑制剂和单克隆抗体。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1278-1298. doi: 10.1080/14756366.2022.2052868.
3
Betulin Sulfonamides as Carbonic Anhydrase Inhibitors and Anticancer Agents in Breast Cancer Cells.
桦木醇磺酰胺类化合物作为碳酸酐酶抑制剂和乳腺癌细胞中的抗癌剂。
Int J Mol Sci. 2021 Aug 16;22(16):8808. doi: 10.3390/ijms22168808.
4
Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers.乌瑞得硫酸盐碳酸酐酶 IX/ XII 抑制剂治疗癌症的临床前评价。
Int J Mol Sci. 2019 Dec 2;20(23):6080. doi: 10.3390/ijms20236080.
5
Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia.碳酸酐酶 9 在低氧条件下赋予恶性间皮瘤对铁死亡/细胞凋亡的抗性。
Redox Biol. 2019 Sep;26:101297. doi: 10.1016/j.redox.2019.101297. Epub 2019 Aug 10.
6
The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.氨基磺酸小分子CAIX抑制剂S4调节阿霉素疗效。
PLoS One. 2016 Aug 11;11(8):e0161040. doi: 10.1371/journal.pone.0161040. eCollection 2016.